У нас вы можете посмотреть бесплатно Overcome the limitations of conventional transfection with MaxCyte electroporation или скачать в максимальном доступном качестве, видео которое было загружено на ютуб. Для загрузки выберите вариант из формы ниже:
Если кнопки скачивания не
загрузились
НАЖМИТЕ ЗДЕСЬ или обновите страницу
Если возникают проблемы со скачиванием видео, пожалуйста напишите в поддержку по адресу внизу
страницы.
Спасибо за использование сервиса ClipSaver.ru
Presented By: Peter Gee, Ph.D. Speaker Biography: Peter Gee is a MaxCyte Senior Field Application Scientist specializing in gene editing and stem cell technologies. Following a B.S. in Biochemistry and Molecular Biology at the University of California, Davis, Peter served as a Research Associate in the Biochemical Pharmacology Core Group at Roche Palo Alto, investigating small molecule drugs against viral enzymes. After completing a Ph.D. at the Institute for Virus Research, Kyoto University, Peter did his postdoctoral training in the laboratory of Akitsu Hotta at Kyoto University’s Center for iPS Cell Research and Application, where he developed delivery vehicles of CRISPR-Cas9 ribonucleoprotein complexes utilizing engineered extracellular nanoparticles. Webinar: Overcome the limitations of conventional transfection with MaxCyte electroporation Webinar Abstract: Are low gene editing efficiency or gene expression levels preventing your research from advancing? Is your transfection method killing your cells? Are you struggling to reproduce your initial results when you need to scale-up to transfect millions of cells instead of thousands? Join us as we explore how MaxCyte's electroporation technology can help you to overcome these challenges, and more. Learn about how traditional delivery methods, such as chemical transfection and retroviral transduction, compare to electroporation for transient and stable engineering with plasmid DNA, mRNA, and CRISPR-RNPs. We will also introduce new approaches for larger-scale electroporation that enable faster workflows, which can save researchers weeks of development time. This webinar is for scientists who are struggling to meet the demands of cell engineering in various applications, including cell therapy, cell-based screening and bioproduction. Labroots on Social: Facebook: / labrootsinc Twitter: / labroots LinkedIn: / labroots Instagram: / labrootsinc Pinterest: / labroots SnapChat: labroots_inc